Institutional Review Board: Investigator Responsibilities When Conducting Human Subjects Research

This course is designed to help investigators better meet their obligations for conducting human subject research by clarifying their responsibility (1) to supervise a clinical study in which some study tasks are delegated to employees or colleagues of the investigator or other third parties, and (2) to protect the rights, safety and welfare of study subjects.

Original Release Date: January 2016
Review Date: May 2022; December 2022; June 2023, June 2024

Target Audience

All investigators responsible for human subject research.

Learning Objectives

  • Describe the history and importance of human subjects protection. 
  • Explain why additional protections are needed for vulnerable populations.
  • Delineate the appropriate procedures for recruiting research participants.
  • Implement the requirements and process for obtain informed consent following national evidence-based guidelines and Baptist Health IRB policies and procedures. 
  • Recognize the importance of study design in the protection of research participants.
  • Explain the responsibilities of a principal investigator.
Additional information
Bibliography: 

Office for Human Research Protection
Office for Human Research Protection Compliance & Reporting
Office for Human Research Protection Regulations, Policy & Posting Guidance for Investigators
http://www.hhs.gov/ohrp

Institutional Review Board: Management and Function by Elizabeth A. Bankert & Robert J. Amdur, Second Edition (2006)

Institutional Review Board: Member Handbook by Elizabeth A. Bankert & Robert J. Amdur, Third Edition (2011)

Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. 
Federal Register Document
http://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/index.html

Code of Federal Regulations DHHS Part 45 CFR 46 Protection of Human Subjects
Revised January 19, 2017   Effective July 19, 2018

45 CFR 46 Subpart B
45 CFR 46 Subpart C
45 CFR 46 Subpart D

Food and Drug Administration Clinical Trial Guidance Documents 
http://www.fda.gov/RegulatoryInformation/Guidances/ucm122046.htm

Food and Drug Administration Warning Letters
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/default.htm

Baptist Health South Florida Institutional Review Board Policies and Procedures
BHSF 832.01 Advertisements and Recruiting Materials
BHSF 832.04 Medical Devices
BHSF 832.07 Investigational Drugs and Biologics
BHSF 832.08 Off-Label Use of Marketed Drugs, Biologics and Medical Devices 
BHSF 832.09 Emergency Use of a Drug, Device or Biological Product
BHSF 832.10 Data Safety Monitoring
BHSF 833.00 Informed Consent Process and Documentation
BHSF 833.01 General Requirements of Informed Consent
BHSF 833.03 Vulnerable Subjects
BHSF 834.01 IRB Audit Program
BHSF 834.02 Notification of Noncompliance

Public Responsibility in Medicine and Research (PRIM&R)
Good Clinical Practice (GCP) – December 5, 2010

Course Summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 General certificate of attendance
  • 1.50 Nurse Practitioners
Course opens: 
06/01/2024
Course expires: 
05/31/2027

Faculty

Mark Hauser, M.D., and Amanda Coltes-Rojas, content contributors and reviewers of this educational activity, have no relevant financial relationships with ineligible companies* to disclose, and have indicated that the content will not include off-label or unapproved product usage.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 General certificate of attendance
  • 1.50 Nurse Practitioners
Please login or register for a Baptist Health CME account to take this course.

Required Hardware/Software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome
Microsoft Edge
Microsoft Edge
Safari
Safari
Moxilla Firefox
Mozilla Firefox
Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.